• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

盐酸文拉法辛从压制包衣骨架片中释放的调控

Modulation of venlafaxine hydrochloride release from press coated matrix tablet.

作者信息

Gohel M C, Soni C D, Nagori S A, Sarvaiya K G

机构信息

Department of Pharmaceutics and Pharmaceutical Technology, L. M. College of Pharmacy, Navrangpura, Ahmedabad-380 009, India.

出版信息

Indian J Pharm Sci. 2008 May-Jun;70(3):292-7. doi: 10.4103/0250-474X.42974.

DOI:10.4103/0250-474X.42974
PMID:20046735
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2792530/
Abstract

The aim of present study was to prepare novel modified release press coated tablets of venlafaxine hydrochloride. Hydroxypropylmethylcellulose K4M and hydroxypropylmethylcellulose K100M were used as release modifier in core and coat, respectively. A 3(2) full factorial design was adopted in the optimization study. The drug to polymer ratio in core and coat were chosen as independent variables. The drug release in the first hour and drug release rate between 1 and 12 h were chosen as dependent variables. The tablets were characterized for dimension analysis, crushing strength, friability and in vitro drug release. A check point batch, containing 1:2.6 and 1:5.4 drug to polymer in core and coat respectively, was prepared. The tablets of check point batch were subjected to in vitro drug release in dissolution media with pH 5, 7.2 and distilled water. The kinetics of drug release was best explained by Korsmeyer and Peppas model (anomalous non-Fickian diffusion). The systematic formulation approach enabled us to develop modified release venlafaxine hydrochloride tablets.

摘要

本研究的目的是制备新型盐酸文拉法辛控释压制包衣片。羟丙基甲基纤维素K4M和羟丙基甲基纤维素K100M分别用作片芯和包衣的释放调节剂。在优化研究中采用了3(2)全因子设计。将片芯和包衣中的药物与聚合物比例选为自变量。将第1小时的药物释放和1至12小时之间的药物释放速率选为因变量。对片剂进行尺寸分析、抗压强度、脆碎度和体外药物释放特性研究。制备了一个检查点批次的片剂,其片芯和包衣中药物与聚合物的比例分别为1:2.6和1:5.4。将检查点批次的片剂在pH值为5、7.2的溶出介质和蒸馏水中进行体外药物释放研究。药物释放动力学最适合用Korsmeyer和Peppas模型(非菲克反常扩散)来解释。系统的制剂方法使我们能够开发出盐酸文拉法辛控释片。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e14/2792530/d2ba83ca48ec/IJPhS-70-292-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e14/2792530/47849c64c696/IJPhS-70-292-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e14/2792530/f80f7b9037c7/IJPhS-70-292-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e14/2792530/d08dfc13690d/IJPhS-70-292-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e14/2792530/538a354049e9/IJPhS-70-292-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e14/2792530/d2ba83ca48ec/IJPhS-70-292-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e14/2792530/47849c64c696/IJPhS-70-292-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e14/2792530/f80f7b9037c7/IJPhS-70-292-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e14/2792530/d08dfc13690d/IJPhS-70-292-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e14/2792530/538a354049e9/IJPhS-70-292-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e14/2792530/d2ba83ca48ec/IJPhS-70-292-g005.jpg

相似文献

1
Modulation of venlafaxine hydrochloride release from press coated matrix tablet.盐酸文拉法辛从压制包衣骨架片中释放的调控
Indian J Pharm Sci. 2008 May-Jun;70(3):292-7. doi: 10.4103/0250-474X.42974.
2
Press-Coated Aceclofenac Tablets for Pulsatile Drug Delivery: Formulation and In Vitro Evaluations.用于脉冲式给药的压片型醋氯芬酸片:制剂与体外评价
Pharmaceuticals (Basel). 2022 Mar 8;15(3):326. doi: 10.3390/ph15030326.
3
Formulation and optimization of sustained release tablets of venlafaxine resinates using response surface methodology.采用响应面法对文拉法辛树脂酸盐缓释片进行处方设计与优化。
Indian J Pharm Sci. 2009 Jul;71(4):387-94. doi: 10.4103/0250-474X.57287.
4
Development of Bioadhesive Buccal Tablets of Nicorandil Using a Factorial Approach.采用析因法开发尼可地尔生物黏附性口腔片。
Turk J Pharm Sci. 2020 Aug;17(4):388-397. doi: 10.4274/tjps.galenos.2019.09226. Epub 2020 Aug 28.
5
Response surface optimization of sustained release metformin-hydrochloride matrix tablets: influence of some hydrophillic polymers on the release.盐酸二甲双胍缓释骨架片的响应面优化:某些亲水性聚合物对释放的影响
ISRN Pharm. 2012;2012:364261. doi: 10.5402/2012/364261. Epub 2012 Sep 4.
6
In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.含纤维素聚合物混合物的亲水基质片剂中酮洛芬的体外释放。
Drug Dev Ind Pharm. 2013 Nov;39(11):1651-62. doi: 10.3109/03639045.2012.729146. Epub 2012 Oct 24.
7
Characterization of 5-fluorouracil release from hydroxypropylmethylcellulose compression-coated tablets.羟丙基甲基纤维素压制包衣片中5-氟尿嘧啶释放特性的研究
Pharm Dev Technol. 2007;12(2):203-10. doi: 10.1080/10837450601168722.
8
Development and in vitro evaluation of an oral floating matrix tablet formulation of diltiazem hydrochloride.盐酸地尔硫䓬口腔漂浮型骨架片制剂的研制与体外评价
AAPS PharmSciTech. 2007 Sep 7;8(3):E73. doi: 10.1208/pt0803073.
9
Formulation development of carvedilol compression coated tablet.卡维地洛压片的制剂开发。
Pharm Dev Technol. 2013 Jul-Aug;18(4):906-15. doi: 10.3109/10837450.2011.598167. Epub 2011 Jul 28.
10
Advanced formulation design of venlafaxine hydrochloride coated and triple-layer tablets containing hypromellose.盐酸文拉法辛包衣和含有羟丙甲纤维素的三层片的高级制剂设计。
Pharm Dev Technol. 2009;14(6):650-8. doi: 10.3109/10837450902911911.

引用本文的文献

1
Optimization and in vivo pharmacokinetic study of a novel controlled release venlafaxine hydrochloride three-layer tablet.新型盐酸文拉法辛三层控释片的优化及体内药代动力学研究。
AAPS PharmSciTech. 2010 Sep;11(3):1026-37. doi: 10.1208/s12249-010-9467-z. Epub 2010 Jun 8.

本文引用的文献

1
Design and study of rifampicin oral controlled release formulations.利福平口服控释制剂的设计与研究
Drug Deliv. 2004 Sep-Oct;11(5):311-7. doi: 10.1080/10717540490494087.
2
Once-daily sustained-release matrix tablets of nicorandil: formulation and in vitro evaluation.尼可地尔每日一次缓释骨架片:制剂与体外评价
AAPS PharmSciTech. 2003 Dec 12;4(4):E61. doi: 10.1208/pt040461.
3
MECHANISM OF SUSTAINED-ACTION MEDICATION. THEORETICAL ANALYSIS OF RATE OF RELEASE OF SOLID DRUGS DISPERSED IN SOLID MATRICES.缓释药物的作用机制。分散于固体基质中的固体药物释放速率的理论分析。
J Pharm Sci. 1963 Dec;52:1145-9. doi: 10.1002/jps.2600521210.
4
Analysis of data on the medicament release from ointments.软膏剂药物释放数据的分析
J Pharm Sci. 1962 Aug;51:802-4. doi: 10.1002/jps.2600510825.
5
Rate of release of medicaments from ointment bases containing drugs in suspension.含有混悬药物的软膏基质中药物的释放速率。
J Pharm Sci. 1961 Oct;50:874-5. doi: 10.1002/jps.2600501018.
6
New methods characterizing avalanche behavior to determine powder flow.用于确定粉末流动的雪崩行为特征的新方法。
Pharm Res. 2002 Jun;19(6):887-93. doi: 10.1023/a:1016125420577.
7
Once daily sustained release tablets of venlafaxine, a novel antidepressant.新型抗抑郁药文拉法辛的每日一次缓释片。
Eur J Pharm Biopharm. 2002 Jul;54(1):9-15. doi: 10.1016/s0939-6411(02)00049-8.
8
Studies in release behavior of diltiazem HCl from matrix tablets containing (hydroxypropyl)methyl cellulose and xanthan gum.盐酸地尔硫䓬从含有(羟丙基)甲基纤维素和黄原胶的骨架片中释放行为的研究。
Boll Chim Farm. 2002 Jan-Feb;141(1):21-8.
9
Venlafaxine. A review of its pharmacology and therapeutic potential in depression.文拉法辛。其药理学及在抑郁症治疗中的潜在作用综述。
Drugs. 1995 Feb;49(2):280-94. doi: 10.2165/00003495-199549020-00010.
10
Mechanisms of potassium chloride release from compressed, hydrophilic, polymeric matrices: effect of entrapped air.氯化钾从压缩的亲水性聚合物基质中释放的机制:截留空气的影响。
J Pharm Sci. 1983 Oct;72(10):1189-91. doi: 10.1002/jps.2600721021.